Kenvue INC Form 4 insider transactions

NYSE
Kimberly-Clark and Kenvue Inc. jointly announced a proposed transaction aimed at creating a global health and wellness leader, emphasizing shared values and future integration.
NYSE
Kimberly-Clark announces its intent to acquire Kenvue, aiming to create a global health and wellness leader by combining their complementary consumer health portfolios.
NYSE
Kimberly-Clark and Kenvue Inc. filed a Form 425 outlining the proposed transaction, emphasizing the need for investor review of future SEC documents.
NYSE
Kimberly-Clark announces an agreement to acquire Kenvue, a pure-play consumer health company, expecting to accelerate growth and innovation.
NYSE
Kimberly-Clark Corporation announced a transformational acquisition of Kenvue Inc. for approximately $48.7 billion, creating a global health and wellness leader.
NYSE
Kimberly-Clark announced an agreement to acquire Kenvue, aiming to create a global health and wellness leader with iconic brands.
NYSE
Kimberly-Clark announced an agreement to acquire Kenvue, aiming to create a global health and wellness leader with a combined portfolio of iconic brands.
NYSE
Kimberly-Clark announced an agreement to acquire Kenvue, aiming to create a global health and wellness leader with an expanded consumer offering.
NYSE
Kimberly-Clark Corporation announced its intent to acquire Kenvue Inc., forming a $32 billion global health and wellness leader.
NYSE
Kimberly-Clark announces its intent to acquire Kenvue, creating a $32 billion global health and wellness leader with significant synergies and growth potential.
NYSE
Kenvue Inc. provides an update on its proposed transaction with Kimberly-Clark Corporation, directing investors to future SEC filings for detailed information.
NYSE
Kenvue announced an agreement to combine with Kimberly-Clark, creating a $32 billion global health and wellness leader, with completion expected in the second half of 2026.
NYSE
Kimberly-Clark and Kenvue announce a merger to create a global health and wellness leader with complementary iconic brands.
NYSE
Kenvue Inc. announced an agreement to combine with Kimberly-Clark, creating a $32 billion global health and wellness leader.
NYSE
Kimberly-Clark Corporation announced an agreement to acquire Kenvue Inc. for approximately $48.7 billion in a cash and stock transaction, creating a global health and wellness leader.
NYSE
Kenvue's VP & Chief Accounting Officer, Heather Howlett, acquired common stock through RSU vesting and subsequently sold shares for tax obligations.
NYSE
Kenvue's Chief Technology & Data Officer, Michael Wondrasch, was granted 189,274 Restricted Stock Units, vesting over three years.
NYSE
Kenvue Director Jeffrey C. Smith filed a Form 4 detailing his indirect beneficial ownership of over 20 million common shares via Starboard Value LP and an acquisition of 1,204 Deferred Share Units.
NYSE
Kenvue Director Sarah Hofstetter acquired 1,204 Deferred Share Units, bringing her total beneficial ownership to 12,045.728 units.
NYSE
Kenvue Inc. Director Richard E. Allison Jr. acquired 1,204 Deferred Share Units, increasing his total beneficial ownership to 34,045.048 units.
NYSE
Kenvue Inc. CEO Kirk Perry acquired 185 Deferred Share Units as pro-rated compensation for his service as an independent director, increasing his total beneficial ownership to 14,041.285 DSUs.
NYSE
Kenvue's Group President APAC, Anindya Dasgupta, received substantial equity awards, including Restricted Stock Units and Stock Options.
NYSE
Kenvue Inc. CEO Kirk Perry was granted 117,150 Restricted Stock Units and 614,250 stock options, vesting in 2026.
NYSE
Kenvue Inc. Director Jeffrey C. Smith has reported an indirect beneficial ownership of over 20.9 million common shares through Starboard Value LP and the direct acquisition of 1,061 Deferred Share Units as part of his compensation plan.
NYSE
Kenvue Inc. Director Sarah Hofstetter acquired 1,061 Deferred Share Units on June 30, 2025, as part of her deferred compensation plan, increasing her total beneficial ownership to 10,734.384 DSUs.
NYSE
Kenvue Inc. Director Kirk Perry reported the acquisition of 1,061 Deferred Share Units (DSUs) as part of his compensation, increasing his total beneficial ownership to 13,719.095 DSUs.
NYSE
Kenvue Inc. Director Richard E. Allison Jr. acquired 1,061 Deferred Share Units (DSUs) on June 30, 2025, as part of his compensation plan, increasing his total beneficial ownership to 32,515.889 DSUs.
NYSE
Kenvue Inc.'s Chief Corporate Affairs Officer, Russell Dyer, reported the vesting of Restricted Stock Units and the subsequent acquisition of common stock, with a portion withheld for tax obligations.
NYSE
Kenvue Inc.'s Chief Financial Officer, Amit Banati, was granted 196,028 Restricted Stock Units and 225,352 Stock Options on June 2, 2025, as part of his compensation package.
NYSE
Kenvue Inc. Director Jeffrey C. Smith reported the acquisition of 7,659 Deferred Share Units (DSUs) as part of director compensation, alongside his substantial indirect beneficial ownership of over 20.9 million common shares through Starboard Value LP.